MDIC’s Case for Quality collaborative community (CfQcc) is announcing the transition of the Case for Quality Voluntary Improvement Program (CfQ VIP) from a pilot to a full program. This transition is separate from FDA efforts to develop a program that engages with CfQ VIP.
In 2018, MDIC supported the FDA/CDRH’s Voluntary Medical Device Manufacturing and Product Quality Pilot Program with the goal of evaluating a way to assess quality system maturity and modifying regulatory requirements to accelerate improvements in medical device manufactures.
In 2019, the program was renamed to its present name, CfQ VIP, and a new working group was established to guide the development of a concept of operations and strategic plan for this program. The transition of CfQ VIP from a pilot to a full program allows the continuation of this highly innovative and quality-focused program for stakeholders across the medical device ecosystem to improve quality and patient outcomes.
Learn more about the CfQcc here.
